Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeguang Wu

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of General Virology|September 19, 2015
Resistant mutations and quasispecies complexity of hepatitis B virus during telbivudine treatmentFeifei Yin, Zeguang Wu, Wei Fang, et al.
Immunologic Research|October 21, 2015
A disparate subset of double-negative T cells contributes to the outcome of murine fulminant viral hepatitis via effector molecule fibrinogen-like protein 2Di Wu, Hongwu Wang, Weiming Yan, et al.
Cellular & Molecular Immunology|February 20, 2024
Unsynchronized butyrophilin molecules dictate cancer cell evasion of Vγ9Vδ2 T-cell killingZeguang Wu, Qiezhong Lamao, Meichao Gu, et al.
Science China. Life Sciences|March 2, 2022
Gene editing and its applications in biomedicineGuanglei Li, Xiangyang Li, Songkuan Zhuang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2021
Human Cytomegalovirus Infection Promotes Expansion of a Functionally Superior Cytoplasmic CD3<sup>+</sup> NK Cell Subset with a Bcl11b-Regulated T Cell SignatureZeguang Wu, Colleen M Lau, Rosa Sottile, et al.
Theranostics|May 23, 2017
Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responsesMichael Schmitt, Anita Schmitt, Markus Wiesneth, et al.
Cell|April 23, 2022
Circular RNA vaccines against SARS-CoV-2 and emerging variantsLiang Qu, Zongyi Yi, Yong Shen, et al.
Cell|August 22, 2025
Glycan shielding enables TCR-sufficient allogeneic CAR-T therapyZeguang Wu, Jinhong Shi, Qiezhong Lamao, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of General Virology|September 19, 2015
Resistant mutations and quasispecies complexity of hepatitis B virus during telbivudine treatmentFeifei Yin, Zeguang Wu, Wei Fang, et al.
Immunologic Research|October 21, 2015
A disparate subset of double-negative T cells contributes to the outcome of murine fulminant viral hepatitis via effector molecule fibrinogen-like protein 2Di Wu, Hongwu Wang, Weiming Yan, et al.
Cellular & Molecular Immunology|February 20, 2024
Unsynchronized butyrophilin molecules dictate cancer cell evasion of Vγ9Vδ2 T-cell killingZeguang Wu, Qiezhong Lamao, Meichao Gu, et al.
Science China. Life Sciences|March 2, 2022
Gene editing and its applications in biomedicineGuanglei Li, Xiangyang Li, Songkuan Zhuang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2021
Human Cytomegalovirus Infection Promotes Expansion of a Functionally Superior Cytoplasmic CD3<sup>+</sup> NK Cell Subset with a Bcl11b-Regulated T Cell SignatureZeguang Wu, Colleen M Lau, Rosa Sottile, et al.
Theranostics|May 23, 2017
Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responsesMichael Schmitt, Anita Schmitt, Markus Wiesneth, et al.
Cell|April 23, 2022
Circular RNA vaccines against SARS-CoV-2 and emerging variantsLiang Qu, Zongyi Yi, Yong Shen, et al.
Cell|August 22, 2025
Glycan shielding enables TCR-sufficient allogeneic CAR-T therapyZeguang Wu, Jinhong Shi, Qiezhong Lamao, et al.
Pageof 3